Key Highlights

  • Maximus reported fiscal third quarter 2026 revenue of $1.28 billion, in line with expectations, with adjusted EBITDA margin of 15.0 percent and adjusted EPS of $2.22.
  • A customer-directed pause in performance incentives on the VA Medical Disability Exam program is expected to reduce full-year adjusted EPS guidance by approximately $0.35.
  • Full-year adjusted diluted EPS guidance was revised to a range of $7.90 to $8.20, with free cash flow guidance now between $425 million and $475 million.
  • The company's total sales pipeline stood at $50.4 billion as of June 30, with $1.25 billion in year-to-date signed contract awards and $1.35 billion awarded but not yet signed.

VA Incentive Pause Drives Guidance Cut Despite In-Line Quarter

Maximus (NYSE:MMS) reported third quarter revenue of $1.28 billion, consistent with expectations and enabling the company to reiterate full-year revenue guidance of $5.2 billion to $5.35 billion, albeit with a bias toward the lower end. Adjusted EBITDA margin came in at 15.0 percent and adjusted EPS was $2.22, both ahead of the prior-year period. U.S. Federal Services segment revenue of $721 million reflected the absence of elevated natural disaster support and temporary clinical volume surges that had lifted the prior-year quarter, while segment operating margin still improved to 18.6 percent from 18.1 percent on continued efficiency gains.

The more significant development was a temporary, customer-directed pause in performance incentives and disincentives on the VA Medical Disability Exam program, effective July 1, 2026, tied to the agency's effort to improve its invoice review and validation process. Because Maximus had earned positive incentives in each of the first three quarters of fiscal 2026, removing any assumed fourth-quarter contribution reduces full-year adjusted diluted EPS guidance by approximately $0.35, bringing the new range to $7.90 to $8.20 with a midpoint of $8.05.

Draft VA Procurement Document Offers Early Reassurance

Management said the current incentive pause is expected to last 180 days, with a possible six-month extension to the underlying contracts to align with a new procurement the VA is pursuing. A draft performance work statement released during the quarter, with a vendor comment period closing August 12, covers all six regions currently served by Maximus and appears consistent with how the work is performed today, a signal the company views as encouraging even though it contains no pricing or incentive structure details.

Should the successor contract ultimately restructure or eliminate the incentive mechanism altogether, the roughly $0.35 per-quarter contribution embedded in recent results may not fully return even after the pause lifts. Management characterized fourth-quarter earnings power, implying a 13 percent adjusted EBITDA margin, as a reasonable run rate entering fiscal 2027 under the current incentive suspension, while acknowledging it remains uncertain how the next contract will ultimately be structured.

SNAP and Medicaid Pipeline Build Toward 2027, Federal Civilian Procurement Slows

U.S. Services segment revenue of $418 million continued closing the gap to prior-year levels, with management forecasting a return to positive mid-single-digit organic growth in the fourth quarter as Medicaid-related beneficiary outreach activity picks up ahead of the January 2027 implementation of federal work requirements. SNAP-related opportunities are advancing somewhat faster, supported by more than 40 demonstrations of the company's Accuracy Assistant tool and a national payment error rate that held roughly flat at 10.6 percent, reinforcing state-level urgency around program integrity ahead of new cost-sharing requirements beginning October 1.

Within the federal civilian market, management noted that some opportunities have experienced procurement delays, scope revisions, or cancellations as agencies navigate budget and policy uncertainty, resulting in more bridge contracts and short-term extensions and a trailing 12-month book-to-bill ratio of approximately 0.5 times. This procurement uncertainty could continue to weigh on new-business timing even as the company's defense and national security pipeline, addressing a market it sizes at nearly $47 billion, continues to expand through non-traditional contracting vehicles.

Conclusion

Maximus's guidance cut is narrowly attributable to a single contract mechanism rather than broader demand erosion, and the company's core federal and state services businesses continued to perform in line with expectations during the quarter. The durability of the VA relationship, underscored by a draft procurement scope that mirrors current operations, may limit downside from the incentive pause, though the ultimate structure of the successor contract remains unresolved. With Medicaid and SNAP-related opportunities tied to federal legislation still in early implementation stages, U.S. Services growth may depend more on the pace of state-level operational readiness than on Maximus's own execution.